Research Article
Th9/IL-9 Profile in Human Echinococcosis: Their Involvement in Immune Response during Infection by Echinococcus granulosus
Table 1
Clinical data of the healthy control (HC) and patients with liver echinococcosis before and after treatment.
| | Characteristics | HC
() | CE
() | PCE
() |
| | Age (year) | | | | | 0–18 | 0 | 0 | 0 | | 19–37 | 20 | 23 | 23 | | 38–56 | 5 | 3 | 3 | | >57 | 0 | 1 | 1 | | Sex ratio | | | | | Male : female | 14 : 11 | 17 : 10 | 17 : 10 | | Location | | | | | Right segment | — | 18 | — | | Left segment | — | 7 | — | | Right and lest segment | — | 2 | — | | Lesions | | | | | Diameter (cm) | — | | — | | Residence | | | | | Urban : rural | 22 : 3 | 2 : 25 | 2 : 25 | | Races | | | | | Han | 14 | 15 | 15 | | Uighur | 6 | 2 | 2 | | Kazakh | 3 | 7 | 7 | | Other | 2 | 3 | 3 | | WHO-IWGE classification | | | | | CE1 | — | 5 | — | | CE2 | — | 14 | — | | CE3 | — | 7 | — | | CE4 | — | 1 | — | | CE5 | — | 0 | — | | Administered therapies | | | | | Surgical removal | — | 27 | — | | Albendazole treatment | — | 27 | — | | Relapsing patients | — | 0 | 0 |
|
|
Note. Values are expressed as mean ± SD or number. HC: healthy control; CE: cystic echinococcosis; —: not determined.
|
